TPTX

Turning Point Therapeutics, Inc. Common Stock

Delisted

TPTX was delisted on the 16th of August, 2022.

155 hedge funds and large institutions have $1.24B invested in Turning Point Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 66 increasing their positions, 53 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
155
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5K
Puts
$236K
Net Calls
Net Calls Change

Top Buyers

1 +$22.7M
2 +$18.1M
3 +$10.7M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$9.17M
5
Morgan Stanley
Morgan Stanley
New York
+$6.35M

Top Sellers

1 -$29.3M
2 -$26.1M
3 -$15.6M
4
AG
Artal Group
Luxembourg
-$11.9M
5
FLAM
First Light Asset Management
Minnesota
-$9.16M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$9.43M
27
$9.43M
28
$9.28M
29
$9.06M
30
$8.68M
31
$8.22M
32
$7.54M
33
$5.6M
34
$5.59M
35
$5.52M
36
$5.41M
37
$5.18M
38
$5.18M
39
$4.24M
40
$4.08M
41
$3.26M
42
$3.24M
43
$3.11M
44
$2.76M
45
$2.73M
46
$2.67M
47
$2.45M
48
$2.23M
49
$2.23M
50
$2.19M